Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company

Genentech is dismantling its cancer immunology team in a reorganization of its work in the field, and its VP of cancer immunology, Ira Mellman, will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities – Pharmaceutical Technology

In this photo illustration Merck logo is seen on a mobile phone and a computer screen. Credit: viewimage via Shutterstock Merck KGaA has announced two

September 20, 2023

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

A study in “Nutrients” reveals that sesame protein-derived peptides, Ala-Gly-Gly-Val-Pro-Arg and Ser-Thr-Ile-Arg, show effective antibacterial activity against Escherichia coli and Staphylococcus aureus.

January 8, 2024

Q&A: Jade CEO talks about reverse merger and IgAN drugs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.